The Gut-Brain Axis in Health and Disease
The gut microbiome has recently been identified as a key regulator of brain health. Intestinal bacteria produce metabolites that can affect brain development, function and pathology. Changes in the gut microbiome have been implied in several brain disorders such as multiple sclerosis, stroke and Alzheimer’s disease. This workshop will highlight the most recent advances and the current understanding of the connection along the gut-brain axis in health and disease. It will also cover the role of the microbiome in neurodevelopment, acute and chronic brain disorders and discuss next steps towards clinical translation.
Teilnehmer sind u.a.: Paul Enck (Tübingen), Frida Hållenius (Lund), Rochellys Diaz Heijtz (Karolinska Institutet Stockholm), Gurumoorthy Krishnamoorthy (MPI für Biochemie).
Keynote Lecture am 6. Juni um 18.30 Uhr:
Carlos Ribeiro, Ph.D. – "How Nutrients, Neuronal Circuits, and the Microbiome Shape Nutritional Decisions"
Carlos Ribeiro leitet die Gruppe "Behaviour and Metabolism" am Champalimaud Centre in Lissabon im Rahmen des Champalimaud Neuroscience Programme.
Ort und Anmeldung
CAS, Seestraße 13, 80802 München